Literature DB >> 25152080

A three-year follow-up study of the development of joint contractures in 131 patients with systemic sclerosis.

Z Bálint1, H Farkas, N Farkas, T Minier, G Kumánovics, K Horváth, A I Solyom, L Czirják, C Varjú.   

Abstract

OBJECTIVES: To analyse the correlation between the number of joint-contractures and other major clinical findings in a follow-up study of 131 patients with systemic sclerosis (SSc).
METHODS: The range of motion of joints (ROM), HAQ-DI, and the major clinical characteristics were assessed.
RESULTS: A high frequency of contractures (ROM<75% of the normal) were present at baseline in small joints of the hand (82%), wrists (75%), and shoulders (50%). ROM of the dominant side hand was significantly more decreased compared to the non-dominant side. The number of the upper extremity contractures correlated positively with ESR (p<0.01), CRP (p<0.01), HAQ-DI (p<0.01), and negatively with forced vital capacity (FVC) (p<0.05). The number of contractures was not significantly different in cases with early (≤ 4 years) and late disease duration in both the limited and diffuse subgroups. During the three-year follow-up period, an increase in the number of joint contractures (ROM<75%) was associated with an increase of ESR, modified Rodnan's skin score, and the European Scleroderma Study Group Activity Index by multiple linear regression analysis. Univariate analysis over a six-year period demonstrated poor outcome in patients with more than ten contractures, or more than four contractures of unilateral hand-joints.
CONCLUSIONS: Contractures predominantly develop during the early years following disease onset in both SSc subgroups. Inflammation and skin-involvement are significant contributing factors for the development of contractures. The dominant hand may be more pronouncedly impaired compared to the non-dominant side. A high number of joint-contractures might be an unfavourable prognostic factor in SSc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25152080

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.

Authors:  Amber Young; Rajaie Namas; Carole Dodge; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-07-19

2.  Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis.

Authors:  M M Sampaio-Barros; J C Alvarenga; L Takayama; A P L Assad; P D Sampaio-Barros; R M R Pereira
Journal:  Osteoporos Int       Date:  2019-04-27       Impact factor: 4.507

3.  Predictors of Hand Contracture in Early Systemic Sclerosis and the Effect on Function: A Prospective Study of the GENISOS Cohort.

Authors:  Maryam Buni; Joyce Joseph; Claudia Pedroza; Sam Theodore; Deepthi Nair; Terry A McNearney; Hilda T Draeger; John D Reveille; Shervin Assassi; Maureen D Mayes
Journal:  J Rheumatol       Date:  2019-02-01       Impact factor: 4.666

4.  Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.

Authors:  Susan L Murphy; Mary Whitehouse Barber; Kate Homer; Carole Dodge; Gary R Cutter; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11       Impact factor: 4.794

5.  Difficulty with daily activities involving the lower extremities in people with systemic sclerosis.

Authors:  Janet L Poole; Jane Brandenstein
Journal:  Clin Rheumatol       Date:  2015-12-10       Impact factor: 2.980

6.  Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trial.

Authors:  Susan L Murphy; Mary Barber; Suiyuan Huang; Maya Sabbagh; Gary Cutter; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.580

Review 7.  Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).

Authors:  Henrik Pettersson; Helene Alexanderson; Janet L Poole; Janos Varga; Malin Regardt; Anne-Marie Russell; Yasser Salam; Kelly Jensen; Jennifer Mansour; Tracy Frech; Carol Feghali-Bostwick; Cecília Varjú; Nancy Baldwin; Matty Heenan; Kim Fligelstone; Monica Holmner; Matthew R Lammi; Mary Beth Scholand; Lee Shapiro; Elizabeth R Volkmann; Lesley Ann Saketkoo
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-07-01       Impact factor: 4.991

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.